S. pneumoniae transmission according to inclusion in conjugate vaccines: Bayesian analysis of a longitudinal follow-up in schools
2006

Transmission of S. pneumoniae in Schools and Vaccine Impact

Sample size: 4488 publication Evidence: moderate

Author Information

Author(s): Cauchemez Simon, Temime Laura, Valleron Alain-Jacques, Varon Emmanuelle, Thomas Guy, Guillemot Didier, Boëlle Pierre-Yves

Primary Institution: INSERM U707, Paris, France

Hypothesis

Do vaccine serotypes have a competitive advantage over non-vaccine serotypes in terms of transmission and carriage duration?

Conclusion

In 3–6 years old children, there is no competitive advantage for vaccine serotypes compared to non-vaccine serotypes.

Supporting Evidence

  • The mean duration of carriage was similar for both vaccine and non-vaccine serotypes.
  • The Secondary Attack Rate was also comparable between vaccine and non-vaccine serotypes.
  • The study included a large cohort of 4,488 children.

Takeaway

The study found that vaccine and non-vaccine types of bacteria stay in children's bodies for about the same amount of time and spread similarly.

Methodology

A Bayesian approach using Markov chain Monte Carlo techniques was applied to analyze oropharyngeal swabs collected from schoolchildren over five months.

Potential Biases

Potential underestimation of carriage duration due to the sensitivity of oropharyngeal swabbing.

Limitations

The study only included children aged 3-6 years and did not account for dual colonization.

Participant Demographics

Children aged 3-6 years from 81 schools in France.

Statistical Information

Confidence Interval

95% CI: 21, 25 days for vaccine serotypes; 95% CI: 20, 24 days for non-vaccine serotypes.

Digital Object Identifier (DOI)

10.1186/1471-2334-6-14

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication